The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth
Open accessAbstract
Some solid tumors have reduced posttranscriptional RNA editing by adenosine deaminase acting on RNA (ADAR) enzymes, but the functional significance of this alteration has been unclear. Here, we found the primary RNA-editing enzyme ADAR1 is frequently reduced in metastatic melanomas. In situ analysis of melanoma samples using progression tissue microarrays indicated a substantial downregulation of ADAR1 during the metastatic transition. Further, ADAR1 knockdown altered cell morphology, promoted in vitro proliferation, and markedly enhanced the tumorigenicity in vivo. A comparative whole genome expression microarray analysis revealed that ADAR1 controls the expression of more than 100 microRNAs (miRNAs) that regulate many genes associated with the observed phenotypes. Importantly, we discovered that ADAR1 fundamentally regulates miRNA processing in an RNA binding–dependent, yet RNA editing–independent manner by regulating Dicer expression at the translational level via let-7. In addition, ADAR1 formed a complex with DGCR8 that was mutually exclusive with the DGCR8-Drosha complex that processes pri-miRNAs in the nucleus. We found that cancer cells silence ADAR1 by overexpressing miR-17 and miR-432, which both directly target the ADAR1 transcript. We further demonstrated that the genes encoding miR-17 and miR-432 are frequently amplified in melanoma and that aberrant hypomethylation of the imprinted DLK1-DIO3 region in chromosome 14 can also drive miR-432 overexpression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · cited 1×
“Another melanoma suppressive protein, IGFBP7, which promotes apoptosis and senescence, operates in nevi bearing the BRAF V600E mutation and is then silenced by methylation in metastatic cells (41).”
Cited by
Deciphering miRNAs’ Action through miRNA Editing
Correia de Sousa, M., Gjorgjieva, M., Dolicka, D., Sobolewski, C., & Foti, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246249 · Cited by 813
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Han, L., Diao, L., Yu, S., Xu, X., Li, J., Zhang, R., Yang, Y., Werner, H. M. J., Eterovic, A. K., Yuan, Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.08.013 · Cited by 542
The Pivotal Regulatory Landscape of RNA Modifications
Li, S., & Mason, C. E. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025405 · Cited by 374
Adenosine-to-inosine RNA editing and human disease
Slotkin, W., & Nishikura, K. (2013) · Genome Medicine · doi:10.1186/gm508 · Cited by 296
Stellos, K., Gatsiou, A., Stamatelopoulos, K., Perisic Matic, L., John, D., Lunella, F. F., Jaé, N., Rossbach, O., Amrhein, C., Sigala, F., et al. (2016) · Nature Medicine · doi:10.1038/nm.4172 · Cited by 285
Metadata
- Authors
- Nemlich, Y., Greenberg, E., Ortenberg, R., Besser, M. J., Barshack, I., Jacob-Hirsch, J., Jacoby, E., Eyal, E., Rivkin, L., Prieto, V. G., Chakravarti, N., Duncan, L. M., Kallenberg, D. M., Galun, E., Bennett, D. C., Amariglio, N., Bar-Eli, M., Schachter, J., Rechavi, G., & Markel, G.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-05-24
- Volume
- 123
- Issue
- 6
- Pages
- 2703-2718
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2029728313
- Cited by
- 167
- References
- 5
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. https://app.cochat.ai/papers/10.1172/jci62980
- The paper
- Nemlich, Y., Greenberg, E., Ortenberg, R., Besser, M. J., Barshack, I., Jacob-Hirsch, J., Jacoby, E., Eyal, E., Rivkin, L., Prieto, V. G., Chakravarti, N., Duncan, L. M., Kallenberg, D. M., Galun, E., Bennett, D. C., Amariglio, N., Bar-Eli, M., Schachter, J., Rechavi, G., & Markel, G. (2013). MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. Journal of Clinical Investigation. https://doi.org/10.1172/jci62980
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.